Biophy
biophy.ai
Artificial Intelligence
Drug Discovery
Biotechnology
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$6.6M
1 round on record
Latest round
$6.6M
Venture round · Mar 2025 · 19 mo ago
Team
11-50
employees, estimated range
The money's age
Due for its next round
19 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 4, 2025
Raised a round Venture round $6.6M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Mar 2025 | $6.6M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | BIOPHY, INC. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
David Latshaw IiExecutive Officer, DirectorSEC Form D
Caitlin Jaye-YanExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
backs Sequence Bio, AbInitio Bio
backs Sequence Bio
backs Windward Bio
backs Metanova Labs
backs Windward Bio
Similar startupsby what they do, their industry and backers
Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological…
Abinitio bio is the AI-native operating platform for drug development and manufacturing.
SYNthesis Med Chem is a global provider of small molecule drug discovery services and offers a unique support to drug discovery projects.
Metanova Labs is an AI drug discovery company building a new model for discovering and developing novel therapeutics. Through NOVA, its…
Solutions for drug discovery and diagnostics. SPR analysis, antibody selection and LFA services. K-One sensor chips & bioconjugates supply.
We study the genetic causes of inherited disease to push drug discovery forward with the right targets and predictors of drug response from…
Overview
We are BioPhy, a healthcare fintech company committed to enhancing outcomes for patients and creating value for investors using our patent-pending AI drug development technology. BioPhy is pioneering new approaches that will unleash a wave of drug discovery innovation.
People
David Latshaw Ii
Executive Officer, Director
Caitlin Jaye-Yan
Executive Officer
Philip Browne
Director
Daniel Sciubba
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Philadelphia
United States
HQ
10-50 est. staff
Financials
Total raised
$6.6M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | $6.6M | Details |